What is it about?
Glycans, variable structures at immune antibodies, modulate immune function. In a large group of healthy women and men, we found that specific glycan structures at immune antibodies in the blood are associated with the risk of developing type 2 diabetes and cardiovascular diseases.
Featured Image
Read the Original
This page is a summary of: Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease, Diabetes Care, October 2022, American Diabetes Association,
DOI: 10.2337/dc22-0833.
You can read the full text:
Contributors
The following have contributed to this page
